Abstract
CT alone has conventionally informed radiotherapy planning. It provides anatomical information for delineation and electron density for dose calculation. Integrating PET-CT for radiotherapy planning offers the opportunity to individualize treatment and improve patient outcome. PET-CT’s molecular insight of tumour biology could facilitate a move away from ‘one-size-fits-all’ prescription to more accurate personalized radiotherapy [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mankoff DA. A definition of molecular imaging. J Nucl Med. 2007;48(6):18N–21N.
De Ruysscher D, Kirsch CM. PET scans in radiotherapy planning of lung cancer. Radiother Oncol. 2010;96(3):335–8.
Chiti A, Kirienko M, Gregoire V. Clinical use of PET-CT data for radiotherapy planning: what are we looking for? Radiother Oncol. 2010;96(3):277–9.
Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56(19):4509–15.
Thorwarth D, Geets X, Paiusco M. Physical radiotherapy treatment planning based on functional PET-CT data. Radiother Oncol. 2010;96(3):317–24.
Coffey M, Vaandering A. Patient setup for PET-CT acquisition in radiotherapy planning. Radiother Oncol. 2010;96(3):298–301.
Scripes PG, Yaparpalvi R. Technical aspects of positron emission tomography/computed tomography in radiotherapy treatment planning. Semin Nucl Med. 2012;42(5):283–8.
Bettinardi V, Picchio M, Di Muzio N, Gianolli L, Gilardi MC, Messa C. Detection and compensation of organ/lesion motion using 4D-PET-CT respiratory gated acquisition techniques. Radiother Oncol. 2010;96(3):311–6.
Weber WA. Quantitative analysis of PET studies. Radiother Oncol. 2010;96(3):308–10.
Nestle U, Schaefer-Schuler A, Kremp S, Groeschel A, Hellwig D, Rube C, Kirsch CM. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2007;34(4):453–62.
Acknowledgements
We acknowledge NHS funding to the NIHR Biomedical Research Centre for Cancer and to Cancer Research UK (CRUK).
Conflict of Interest Notification
No conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hafeez, S., Huddart, R. (2017). Advantages and Limitations. In: Chua, S. (eds) PET/CT in Radiotherapy Planning . Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-54744-2_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-54744-2_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54743-5
Online ISBN: 978-3-319-54744-2
eBook Packages: MedicineMedicine (R0)